Combined JAK2 and ERK1/2 kinase inhibition as a novel therapeutic approach in myeloproliferative neoplasms Meeting Abstract
| Authors: | Brkic, S.; Stivala, S.; Santopolo, A.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Levine, R. L.; Meyer, S. C. |
| Abstract Title: | Combined JAK2 and ERK1/2 kinase inhibition as a novel therapeutic approach in myeloproliferative neoplasms |
| Meeting Title: | 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 9-11 |
| Meeting Location: | Virtual |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-10-01 |
| Start Page: | 78 |
| End Page: | 79 |
| Language: | English |
| ACCESSION: | WOS:000575955000191 |
| PROVIDER: | wos |
| DOI: | 10.1159/000510995 |
| Notes: | Meeting Abstract: 434 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos |
